U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C17H35N5O6
Molecular Weight 405.4897
Optical Activity UNSPECIFIED
Defined Stereocenters 10 / 10
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ASTROMICIN

SMILES

[H][C@]1(CC[C@@H](N)[C@@]([H])(O[C@@H]2[C@@H](N)[C@H](O)[C@H](OC)[C@H]([C@H]2O)N(C)C(=O)CN)O1)[C@H](C)N

InChI

InChIKey=BIDUPMYXGFNAEJ-APGVDKLISA-N
InChI=1S/C17H35N5O6/c1-7(19)9-5-4-8(20)17(27-9)28-15-11(21)13(24)16(26-3)12(14(15)25)22(2)10(23)6-18/h7-9,11-17,24-25H,4-6,18-21H2,1-3H3/t7-,8+,9-,11-,12-,13-,14+,15+,16+,17+/m0/s1

HIDE SMILES / InChI

Molecular Formula C17H35N5O6
Molecular Weight 405.4897
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 10 / 10
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: description was created based on several sources, including: http://www.et97.com/view/526697.htm

Astromicin is an aminoglycoside antibiotic produced by Micromonospora spp. It is effective against major gram-negative bacterias such as Proteus, Serratia, Citrobacter, Enterobacter spp., Klebsiella, Escherichia coli and Staphylococcus aureus. Astromicin sulfate has been given by intramuscular injection or intravenous infusion. Side effects are: rash, urticaria, itch, erythema, fever, nausea, vomiting, and diarrhea. Combination with strong diuretics can cause nephrotoxicity and ototoxicity.

Originator

Curator's Comment: Fortimicin B:https://www.google.ch/patents/US3931400

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
Fortimicin

Approved Use

It is used for treatment of bronchitis
Curative
Fortimicin

Approved Use

It is used for treatment of pyelonephritis
Curative
Fortimicin

Approved Use

It is used for treatment of cystitis.
Curative
Fortimicin

Approved Use

It is used for the treatment of pneumonia.
Curative
Fortimicin

Approved Use

It is used for treatment of peritonitis.
PubMed

PubMed

TitleDatePubMed
Neuromuscular blocking effects of the aminoglycoside antibiotics arbekacin, astromicin, isepamicin and netilmicin on the diaphragm and limb muscles in the rabbit.
2001
[Functional characterization of a multiple-antibiotic resistant plasmid from clinical isolates of methicillin-resistant Staphylococcus aureus].
2001 May
Photorhabdus luminescens genes induced upon insect infection.
2008 May 19
Patents

Sample Use Guides

400mg divided into 2 injection
Route of Administration: Intramuscular
In Vitro Use Guide
MIC50 against Pseudomonas aeruginosa is 10 ug/ml
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:40:12 GMT 2023
Edited
by admin
on Fri Dec 15 15:40:12 GMT 2023
Record UNII
7JHD84H15J
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ASTROMICIN
INN   WHO-DD  
INN  
Official Name English
FORTIMICIN A [MI]
Common Name English
Astromicin [WHO-DD]
Common Name English
astromicin [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C2363
Created by admin on Fri Dec 15 15:40:12 GMT 2023 , Edited by admin on Fri Dec 15 15:40:12 GMT 2023
Code System Code Type Description
MESH
C023384
Created by admin on Fri Dec 15 15:40:12 GMT 2023 , Edited by admin on Fri Dec 15 15:40:12 GMT 2023
PRIMARY
NCI_THESAURUS
C76146
Created by admin on Fri Dec 15 15:40:12 GMT 2023 , Edited by admin on Fri Dec 15 15:40:12 GMT 2023
PRIMARY
CAS
55779-06-1
Created by admin on Fri Dec 15 15:40:12 GMT 2023 , Edited by admin on Fri Dec 15 15:40:12 GMT 2023
PRIMARY
CHEBI
37923
Created by admin on Fri Dec 15 15:40:12 GMT 2023 , Edited by admin on Fri Dec 15 15:40:12 GMT 2023
PRIMARY
PUBCHEM
5284517
Created by admin on Fri Dec 15 15:40:12 GMT 2023 , Edited by admin on Fri Dec 15 15:40:12 GMT 2023
PRIMARY
EPA CompTox
DTXSID2022624
Created by admin on Fri Dec 15 15:40:12 GMT 2023 , Edited by admin on Fri Dec 15 15:40:12 GMT 2023
PRIMARY
ChEMBL
CHEMBL3084803
Created by admin on Fri Dec 15 15:40:12 GMT 2023 , Edited by admin on Fri Dec 15 15:40:12 GMT 2023
PRIMARY
SMS_ID
100000086610
Created by admin on Fri Dec 15 15:40:12 GMT 2023 , Edited by admin on Fri Dec 15 15:40:12 GMT 2023
PRIMARY
FDA UNII
7JHD84H15J
Created by admin on Fri Dec 15 15:40:12 GMT 2023 , Edited by admin on Fri Dec 15 15:40:12 GMT 2023
PRIMARY
MERCK INDEX
m5545
Created by admin on Fri Dec 15 15:40:12 GMT 2023 , Edited by admin on Fri Dec 15 15:40:12 GMT 2023
PRIMARY Merck Index
EVMPD
SUB05587MIG
Created by admin on Fri Dec 15 15:40:12 GMT 2023 , Edited by admin on Fri Dec 15 15:40:12 GMT 2023
PRIMARY
WIKIPEDIA
ASTROMICIN
Created by admin on Fri Dec 15 15:40:12 GMT 2023 , Edited by admin on Fri Dec 15 15:40:12 GMT 2023
PRIMARY
DRUG CENTRAL
250
Created by admin on Fri Dec 15 15:40:12 GMT 2023 , Edited by admin on Fri Dec 15 15:40:12 GMT 2023
PRIMARY
INN
4904
Created by admin on Fri Dec 15 15:40:12 GMT 2023 , Edited by admin on Fri Dec 15 15:40:12 GMT 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY